PP13 and Doppler Study to Predict Preeclampsia

NCT00928213 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Preeclampsia

Interventions

DRUG: Progesterone
DRUG: Low molecular weight Heparin
DRUG: No Drug

Sponsor

Ben-Gurion University of the Negev

Collaborators

[object Object]
[object Object]
[object Object]